Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05793567 · ClinicalTrials.gov registry record
A Study of Microcirculatory Function in Type 2 Myocardial Infarction (T2MI)
A clinical trial, sponsored by Mayo Clinic.
- Not yet
- Registry status
- 52
- Enrollment target
NCT05793567: Clinical Trial study, sponsored by Mayo Clinic.
NCT05793567 is a clinical trial that has not yet begun recruiting, run by Mayo Clinic. The registered enrollment target is 52 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05793567 has not yet begun recruiting, sponsored by Mayo Clinic.
- NOT YET RECRUITING
- Registry status
- 52 participants
- Enrollment target
Study Summary
The purpose of this research is to find out if patients with Type 2 Myocardial Infarction (T2MI) without significant epicardial coronary artery disease (CAD) have a greater chance of having coronary microvascular disease (CMD).
Primary Outcome
The CFR will be calculated as a ratio of coronary flow at peak hyperemia /coronary flow at rest.
Interventions
- DIAGNOSTIC_TEST Coronary angiogram with coronary reactivity testing (CRT)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 52 participants |
| Start Date | 2026-08 |
| Est. Completion | 2027-04 |
What is known before NCT05793567 opens enrollment
NCT05793567 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 52 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Coronary angiogram with coronary reactivity testing (CRT) is the first listed.
NCT05793567 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05793567 about?
NCT05793567 is a clinical study titled "A Study of Microcirculatory Function in Type 2 Myocardial Infarction (T2MI)". The purpose of this research is to find out if patients with Type 2 Myocardial Infarction (T2MI) without significant epicardial coronary artery disease (CAD) have a greater chance of having coronary microvascular disease (CMD).
What is the current status of trial NCT05793567?
This trial is currently not yet recruiting. The enrollment target is 52 participants. The study started on 2026-08. Estimated completion is 2027-04.
What interventions are being tested in trial NCT05793567?
The interventions under investigation include: Coronary angiogram with coronary reactivity testing (CRT) (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT05793567?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02630121 · 52 participants · Phase 4
Effect of Oxymetazoline Hydrochloride in Combination With Fluticasone Propionate on the Apnea Hypopnea Index (AHI) in Subject With Persistent Nasal Congestion and Mild Obstructive Sleep Apnea
- NCT03629171 · 52 participants · Phase 2
Liposome-encapsulated Daunorubicin-Cytarabine and Venetoclax in Treating Participants With Relapsed, Refractory or Untreated Acute Myeloid Leukemia
- NCT04128748 · 52 participants · Phase 1
Liposomal Cytarabine and Daunorubicin (CPX-351) and Quizartinib for the Treatment of Acute Myeloid Leukemia and High Risk Myelodysplastic Syndrome
- NCT04150497 · 52 participants · Phase 1
Phase 1/2 Study of UCART22 in Patients With Relapsed or Refractory CD22+ B-cell Acute Lymphoblastic Leukemia (BALLI-01)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia